Sales Are Strong for Glaxoâs Weight-Loss Product
108424
Desperate for a cure for fat, consumers have purchased more than two million starter packages of the new weight-loss product Alli since it launched four months ago.
293172
The first over-the-counter weight-loss pill won approval from U.S. health officials on Wednesday, giving the two-thirds of Americans who are obese or overweight another option to help them shed pounds.
435356
Takeda Pharmaceutical Co. Ltd. , Japan's largest drug maker, posted a strong 13.6 percent rise in nine-month profit on robust sales of its Actos diabetes drug and kept its full-year forecasts.
364253
PARIS Sanofi-Aventis shares rose Monday after the French-German drugmaker reported a clinical study showing its experimental anti-obesity drug succeeded in helping people lose weight.
479126
Strong drug sales provide a dose of good medicine for this pharmaceutical company.
472206
Sales of milk and baby food are making this a much more profitable company.
142333
German chemicals and pharmaceuticals giant Bayer said it had acquired the marketing rights for GlaxoSmithKline's erectile dysfunction treatment Levitra in a number of countries outside the US for 208 million euros (272 million dollars).
233235
NEW YORK  - Insulin, Glucotrol, and drugs like Avandia and Actos are all effective treatments for diabetes, but they can produce weight gain.
165670
thanks to an amazing new experimental drug. A third of the people taking the drug lost at least 10% of their body weight and were able to keep it off for two years.
393883
Schering continues its strong sales and earnings growth.
504002
The company posted strong second-quarter sales, and an acquisition could help long-term results.
411375
GlaxoSmithKline Plc  won U.S. approval for a once-a-day breast cancer pill on Tuesday that the drugmaker hopes will launch a new era for its oncology business.
681361
Australian biotech group Metabolic  Pharmaceuticals Ltd. said on Monday a clinical trial showed its  new weight-loss drug was effective and free of side effects,  sending its shares soaring 28 percent.
670417
PARIS Sanofi-SynthÃ©labo, which this month completed its $63 billion purchase of a rival drug manufacturer, Aventis, reported Tuesday a 21 percent jump in first-half profit on higher demand for the blood thinner Plavix and the cancer treatment Eloxatin.
144217
U.S. prescription drug sales rose 8.3 percent to $274.9 billion last year, fueled by the Medicare drug benefit, increased use of generic medicines and new treatments for diseases such as cancer and diabetes, according to a new report.
693310
The Pfizer painkillers Celebrex and Bextra experienced a jump in sales immediately after rival Merck&#39;s Vioxx was pulled from the market in late September, but the gains appear to be short
339591
Proclaiming an end to the low-carb diet craze, U.S. weight loss companies are launching a marketing blitz aimed at winning over consumers resolved to shed flab once and for all in the New Year.